{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:29:23Z","timestamp":1788791363896,"version":"build-2803163510"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This review examines prevalence, diagnosis, and management strategies for cardiovascular risk factors including dyslipidemia, hypertension, and obesity in children and adolescents. As these risk factors begin in childhood and track into adulthood, early intervention is important in preventing cardiovascular disease, the leading cause of mortality in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>The American Heart Association's Life's Essential 8 characterizes components of cardiovascular health including health behaviors (diet, exercise, sleep, tobacco use) and health factors (blood lipids, blood pressure, blood glucose, and weight). Optimizing these health metrics is associated with favorable overall and cardiovascular health (CVH) outcomes. In the United States, prevalence of hypertension, obesity, and cardiovascular disease is projected to rise over the next decade, while hypercholesterolemia is declining. While lifestyle modifications remain a cornerstone in care, new pharmacotherapeutic options have emerged for children over the past several years to treat dyslipidemia and obesity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Pediatric clinicians have an important role in counseling and supporting CVH in children. This review examines aspects of CVH that are commonly managed in preventive cardiology programs, focusing on diagnostic evaluation and treatment strategies, highlighting new and emerging therapies for children and adolescents, including pharmacotherapy and latest research on effective lifestyle modifications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001614","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:00:21Z","timestamp":1787320821000},"page":"469-476","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The role of preventive cardiology in children"],"prefix":"10.1097","volume":"38","author":[{"given":"Michelle Ghandhi","family":"Degen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"R2-20260907","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1161\/CIR.0000000000001412","article-title":"2026 Heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"153","author":"Palaniappan","year":"2026","journal-title":"Circulation"},{"key":"R3-20260907","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00000441-199512000-00005","article-title":"Rationale to study the early natural history of heart disease: the Bogalusa Heart Study","volume":"310","author":"Berenson","year":"1995","journal-title":"Am J Med Sci"},{"key":"R5-20260907","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's Essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"R7-20260907","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa2109191","article-title":"Childhood cardiovascular risk factors and adult cardiovascular events","volume":"386","author":"Jacobs","year":"2022","journal-title":"N Engl J Med"},{"key":"R8-20260907","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1001\/jama.2024.4819","article-title":"Non\u2013high-density lipoprotein cholesterol levels from childhood to adulthood and cardiovascular disease events","volume":"331","author":"Wu","year":"2024","journal-title":"JAMA"},{"key":"R9-20260907","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"R10-20260907","doi-asserted-by":"crossref","first-page":"e2022060640","DOI":"10.1542\/peds.2022-060640","article-title":"Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity","volume":"151","author":"Hampl","year":"2023","journal-title":"Pediatrics"},{"key":"R11-20260907","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/CIR.0000000000001256","article-title":"Forecasting the burden of cardiovascular disease and stroke in the United States through prevalence of risk factors and disease: a presidential advisory from the American Heart Association","volume":"150","author":"Joynt Maddox","year":"2024","journal-title":"Circulation"},{"key":"R12-20260907","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0022-3476(95)70020-X","article-title":"Effects of secular trends in obesity on coronary risk factors in children: the Bogalusa Heart Study","volume":"127","author":"Gidding","year":"1995","journal-title":"J Pediatr"},{"key":"R13-20260907","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/CIRCULATIONAHA.107.717033","article-title":"Preventing heart disease in the 21st century","volume":"117","author":"McGill","year":"2008","journal-title":"Circulation"},{"key":"R15-20260907","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1542\/peds.2012-1137","article-title":"Guidelines for lipid screening in children and adolescents: bringing evidence to the debate","volume":"130","author":"McCrindle","year":"2012","journal-title":"Pediatrics"},{"key":"R16-20260907","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamapediatrics.2021.2046","article-title":"Low-density lipoprotein cholesterol trajectories and prevalence of high low-density lipoprotein cholesterol consistent with heterozygous familial hypercholesterolemia in US children","volume":"175","author":"Zhang","year":"2021","journal-title":"JAMA Pediatr"},{"key":"R17-20260907","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1542\/pir.2019-0053","article-title":"Hyperlipidemia","volume":"41","author":"Stewart","year":"2020","journal-title":"Pediatr Rev"},{"key":"R19-20260907","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpeds.2022.08.034","article-title":"Preventive medicine in pediatric cardiology practice","volume":"253","author":"Hokanson","year":"2023","journal-title":"J Pediatr"},{"key":"R20-20260907","doi-asserted-by":"crossref","first-page":"e2421724","DOI":"10.1001\/jamanetworkopen.2024.21724","article-title":"Pediatric lipid screening prevalence using nationwide electronic medical records","volume":"7","author":"Thompson-Paul","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R21-20260907","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","article-title":"Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)","volume":"133","author":"de Ferranti","year":"2016","journal-title":"Circulation"},{"key":"R22-20260907","doi-asserted-by":"crossref","first-page":"e013225","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and treatment of heterozygous familial hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R23-20260907","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","article-title":"Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype","volume":"134","author":"Perak","year":"2016","journal-title":"Circulation"},{"key":"R25-20260907","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"R26-20260907","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"R27-20260907","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019\u200aESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"R28-20260907","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia","volume":"72","author":"Sturm","year":"2018","journal-title":"JACC"},{"key":"R29-20260907","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpeds.2022.08.041","article-title":"Factors predicting statin initiation during childhood in familial hypercholesterolemia: importance of genetic diagnosis","volume":"253","author":"Peretti","year":"2023","journal-title":"J Pediatr"},{"key":"R30-20260907","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (lLipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease","volume":"41","author":"Patel","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R31-20260907","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.119.038989","article-title":"Screening for high lipoprotein(a)","volume":"139","author":"Thanassoulis","year":"2019","journal-title":"Circulation"},{"key":"R33-20260907","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2025.03.019","article-title":"Design and rationale of Lp(a)HORIZON trial: assessing the effect of lipoprotein(a) lowering with pelacarsen on major cardiovascular events in patients with CVD and elevated Lp(a)","volume":"287","author":"Cho","year":"2025","journal-title":"Am Heart J"},{"key":"R34-20260907","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacl.2022.07.011","article-title":"Nutrition interventions for youth with dyslipidemia: a National Lipid Association clinical perspective","volume":"16","author":"Williams","year":"2022","journal-title":"J Clin Lipidol"},{"key":"R35-20260907","doi-asserted-by":"crossref","first-page":"1601015","DOI":"10.1002\/mnfr.201601015","article-title":"The Mediterranean diet decreases LDL atherogenicity in high cardiovascular risk individuals: a randomized controlled trial","volume":"61","author":"Hern\u00e1ez","year":"2017","journal-title":"Mol Nutr Food Res"},{"issue":"(S3)","key":"R37-20260907","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/clc.4960221503","article-title":"A dietary approach to prevent hypertension: a review of the dietary approaches to stop hypertension (DASH) study","volume":"22","author":"Sacks","year":"1999","journal-title":"Clin Cardiol"},{"key":"R38-20260907","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1542\/peds.107.2.256","article-title":"Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC)","volume":"107","author":"Obarzanek","year":"2001","journal-title":"Pediatrics"},{"key":"R39-20260907","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2016.08.041","article-title":"Adolescent dyslipidemia and standardized lifestyle modification: benchmarking real-world practice","volume":"68","author":"Zachariah","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R41-20260907","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-Year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"key":"R42-20260907","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.107.717777","article-title":"Statins and children","volume":"116","author":"Stein","year":"2007","journal-title":"Circulation"},{"key":"R43-20260907","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/01.CIR.0000035247.42888.82","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia","volume":"106","author":"de Jongh","year":"2002","journal-title":"Circulation"},{"key":"R44-20260907","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.106.671016","article-title":"Statin treatment in children with familial hypercholesterolemia","volume":"116","author":"Rodenburg","year":"2007","journal-title":"Circulation"},{"key":"R45-20260907","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jpeds.2015.02.043","article-title":"Efficacy and safety of ezetimibe monotherapy in children with heterozygous familial or nonfamilial hypercholesterolemia","volume":"166","author":"Kusters","year":"2015","journal-title":"J Pediatr"},{"key":"R46-20260907","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa2019910","article-title":"Evolocumab in pediatric heterozygous familial hypercholesterolemia","volume":"383","author":"Santos","year":"2020","journal-title":"N Engl J Med"},{"key":"R47-20260907","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2213-8587(25)00351-1","article-title":"Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial","volume":"14","author":"Wiegman","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R48-20260907","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/CIRCULATIONAHA.124.073233","article-title":"Efficacy and safety of inclisiran in adolescents with genetically confirmed homozygous familial hypercholesterolemia: results from the double-blind, placebo-controlled part of the ORION-13 Randomized Trial","volume":"151","author":"Wiegman","year":"2025","journal-title":"Circulation"},{"key":"R49-20260907","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s40265-021-01516-y","article-title":"Evinacumab: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"R50-20260907","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"R51-20260907","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1161\/HYP.0000000000000228","article-title":"Pediatric primary hypertension: an underrecognized condition: a scientific statement From the American Heart Association","volume":"80","author":"Falkner","year":"2023","journal-title":"Hypertension"},{"key":"R52-20260907","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ekir.2022.02.018","article-title":"High blood pressure in children and adolescents: current perspectives and strategies to improve future kidney and cardiovascular health","volume":"7","author":"Robinson","year":"2022","journal-title":"Kidney Int Rep"},{"key":"R53-20260907","doi-asserted-by":"crossref","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"R54-20260907","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJMoa1010112","article-title":"Childhood adiposity, adult adiposity, and cardiovascular risk factors","volume":"365","author":"Juonala","year":"2011","journal-title":"N Engl J Med"},{"key":"R55-20260907","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0895-7061(98)00014-4","article-title":"Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension","volume":"11","author":"Belsha","year":"1998","journal-title":"Am J Hypertens"},{"key":"R56-20260907","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/HYPERTENSIONAHA.120.16896","article-title":"Pediatric and adult ambulatory blood pressure thresholds and blood pressure load as predictors of left ventricular hypertrophy in adolescents","volume":"78","author":"Hamdani","year":"2021","journal-title":"Hypertension"},{"key":"R57-20260907","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1001\/jama.2018.14854","article-title":"The physical activity guidelines for Americans","volume":"320","author":"Piercy","year":"2018","journal-title":"JAMA"},{"key":"R58-20260907","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","article-title":"World Health Organization 2020 guidelines on physical activity and sedentary behaviour","volume":"54","author":"Bull","year":"2020","journal-title":"Br J Sports Med"},{"key":"R59-20260907","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ajh\/hpz174","article-title":"Influence of physical activity on blood pressure in children with overweight\/obesity: a randomized clinical trial","volume":"33","author":"Aguilar-Cordero","year":"2020","journal-title":"Am J Hypertens"},{"key":"R60-20260907","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s41598-022-06017-w","article-title":"The high-intensity interval training introduced in physical education lessons decrease systole in high blood pressure adolescents","volume":"12","author":"Popowczak","year":"2022","journal-title":"Sci Rep"},{"key":"R61-20260907","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.jacc.2009.08.030","article-title":"Physical activity reduces systemic blood pressure and improves early markers of atherosclerosis in pre-pubertal obese children","volume":"54","author":"Farpour-Lambert","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R62-20260907","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1479-5868-10-98","article-title":"A systematic review of the psychological and social benefits of participation in sport for children and adolescents: informing development of a conceptual model of health through sport","volume":"10","author":"Eime","year":"2013","journal-title":"Int J Behav Nutr Phys Act"},{"key":"R63-20260907","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure","volume":"336","author":"Appel","year":"1997","journal-title":"N Engl J Med"},{"key":"R64-20260907","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jpeds.2007.09.022","article-title":"The efficacy of a clinic-based behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure","volume":"152","author":"Couch","year":"2008","journal-title":"J Pediatr"},{"key":"R65-20260907","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpeds.2016.03.077","article-title":"Dietary Approaches to Stop Hypertension (DASH) dietary pattern is associated with reduced incidence of metabolic syndrome in children and adolescents","volume":"174","author":"Asghari","year":"2016","journal-title":"J Pediatr"},{"key":"R66-20260907","first-page":"1764","article-title":"Nicotine and the cardiovascular system: unmasking a global public health threat","volume":"47","author":"M\u00fcnzel","year":"2026","journal-title":"Eur Heart J"},{"key":"R67-20260907","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1161\/RES.0000000000000544","article-title":"Cardiopulmonary consequences of vaping in adolescents: a scientific statement From the American Heart Association","volume":"131","author":"Wold","year":"2022","journal-title":"Circ Res"},{"key":"R68-20260907","doi-asserted-by":"crossref","first-page":"e2037936","DOI":"10.1001\/jamanetworkopen.2020.37936","article-title":"Analysis of active and passive tobacco exposures and blood pressure in US children and adolescents","volume":"4","author":"Levy","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R69-20260907","doi-asserted-by":"crossref","first-page":"21501319241277393","DOI":"10.1177\/21501319241277393","article-title":"The CATCH My breath vaping prevention curriculum: an evaluation of impacts in central appalachian middle and high schools","volume":"15","author":"Burchfield","year":"2024","journal-title":"J Prim Care Community Health"},{"key":"R71-20260907","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1542\/peds.108.1.18","article-title":"A randomized trial to reduce passive smoke exposure in low-income households with young children","volume":"108","author":"Emmons","year":"2001","journal-title":"Pediatrics"},{"key":"R72-20260907","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jama.2023.8061","article-title":"Family-based behavioral treatment for childhood obesity implemented in pediatric primary care: a randomized clinical trial","volume":"329","author":"Epstein","year":"2023","journal-title":"JAMA"},{"key":"R73-20260907","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMcp2102062","article-title":"Obesity in adolescents","volume":"389","author":"Hannon","year":"2023","journal-title":"N Engl J Med"},{"key":"R75-20260907","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jama.2024.6739","article-title":"Interventions for weight management in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"332","author":"O\u2019Connor","year":"2024","journal-title":"JAMA"},{"key":"R76-20260907","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jpeds.2021.01.070","article-title":"Improving cardiovascular health in a pediatric preventive cardiology practice","volume":"232","author":"Gooding","year":"2021","journal-title":"J Pediatr"},{"key":"R77-20260907","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/obr.12714","article-title":"The role and impact of community health workers in childhood obesity interventions: a systematic review and meta-analysis","volume":"19","author":"Schroeder","year":"2018","journal-title":"Obes Rev"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:00:39Z","timestamp":1788789639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001614","relation":{},"ISSN":["1531-698X","1040-8703"],"issn-type":[{"value":"1531-698X","type":"electronic"},{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}